How the Increased Need for Allogeneic Donors Could Impact Cell Therapy Research
Jan. 20, 2020
Patricia Shi, MD, Medical Director & Head of Clinical Research in Sickle Cell Disease
Historically, cell therapy products have relied on autologous cell donations. However, more companies are moving towards allogeneic cells to bring life-saving therapies to greater numbers of patients.